|Title:||Alatrofloxacin parenteral compositions|
|Abstract:||The present invention relates to alatrofloxacin mesylate substantially free of less polar impurities, to parenteral compositions of alatrofloxacin mesylate and to processes for purifying alatrofloxacin mesylate.|
|Inventor(s):||Guinn; Robert Mark (Mystic, CT), Lambert; John Francis (North Stonington, CT), Guhan; Subramanian Sam (Niantic, CT), Walinsky; Stanley Walter (Mystic, CT)|
|Assignee:||Pfizer Inc (New York, NY)|
Patent Claim Types:|
see list of patent claims
|Compound; Process; Use; Composition;|
Field: Not categorized
Back Citations: 14th percentile
Forward Citations: 0th percentile
|Patent Number||Expiration Date|
|6,194,429||February 27, 2013|
|PCT Filed||July 23, 1998||PCT Application Number:||PCT/IB98/01122|
|PCT Publication Date:||February 11, 1999||PCT Publication Number:||WO99/06430|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|European Patent Office||1000086||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.